gender identity disorder, transgender persons, sexual transition,
gender transition, male-to-female, gender non-conform,
gender-transform, gender incongruence
* Key words used in accordance with the PI(C)O method
“transsexualism” OR “transgender” OR “transgenderism” AND (“reassignment surgery” OR “sex reassignment”) AND “quality of life” | |
(DE “Transgender” OR DE “Transsexualism” OR DE “Gender Identity Disorder”) AND (DE “Sex Change” OR DE “Surgery” OR “reassignment surgery” OR “sex reassignment”) AND “quality of life” | |
| (“Transsexualism”[Mesh]) AND (“Sex Reassignment Surgery”[Mesh]) AND (“Quality of Life”[Mesh]) ((“Transgender Persons”[Mesh]) OR “Transsexualism”[Mesh]) AND (“Quality of Life”[Mesh]) (“Quality of life”) AND (“gender reassignment surgery” OR “sex reassignment operation” OR “gender transformation operation” OR “sex reassignment surgery” OR “penile inversion vaginoplasty” AND sex* AND chang* OR sex* AND reassign* OR gender-reassign*) AND (gender-dysphor* OR transsex* OR gender-nonconform* OR gender-non-conform* OR transgend* OR transident* OR gender-incongruence OR gender-varian* OR gender-transform* OR gender-identity-disorder* OR sexual-transition OR gender-transition OR sexual-dysphor* OR transvest* OR autogyn* OR trans-sex* OR trans-gend* OR trans-ident* OR “male-to-female”) |
(gender-dysphor* OR transsex* OR gender-nonconform* OR gender-non-conform* OR trans-gend* OR trans-ident* OR gender-incongruence OR gender-varian* OR gender-transform* OR gender-identity-disorder* OR sexual-transition OR gender-transition OR sexual-dysphor* OR transvest* OR autogyn* OR trans-sex* OR trans-gend* OR trans-ident* OR “male-to-female”) AND (“gender reassignment surgery” OR “sex reassignment operation” OR “gender transformation operation” OR “sex reassignment surgery” OR “penile inversion vaginoplasty” OR sex* chang* OR sex* reassign* OR gender-reassign*) AND (“quality of life”) |
* Catch phrases and key words used in the literature search
Among others, we excluded studies that did not focus exclusively on trans persons or that didn’t collect data on quality of life by using a standardized questionnaire. We also excluded studies in underage trans people.
The Figure shows the study selection process.
Flow chart illustrating the study selection process
All included articles are non-randomized studies with an evidence level of III ( e2 ). In the case of studies that reported on the quality of life of trans women as well as trans men ( 17 – 21 ) we ensured that the data for trans women were evaluated separately or that the ratio of M–F/F–M favored trans women. Table 1 shows further key study data; Table 2 shows the quality characteristics of the studies.
| | | | | ||
) | ||||||
) | | | ||||
) | | |||||
) | | | ||||
| | |||||
) | | | , | |||
) | | | | |||
| | |||||
) | | | ||||
) | | | ||||
) | | | , | |||
) | | | ||||
) | ||||||
) | | |||||
) | | | |
* 1 Numbers of study participants after removal of dropouts ( table 2 ); exception: Lindqvist et al. ( 23 ), see Table 2
* 2 M–F, male-to-female; F–M, female to male, sex reassignment surgery
| ) | |||
Ainsworth et al. ( ) | — | — | n = 25 (10.12%) M–F* had sex reassignment surgery n = 47 (19.02%) had sex reassignment surgery and facial feminization surgery n = 28 (11.3%) had facial feminization surgery n = 147 (59.51%) had no surgery Time of survey not stated, hormone therapy | Moderate to high: selection bias, classification bias, bias owing to deviations in interventions |
Bouman et al. ( ) | 20.51% | Non-respondents n = 6 (15.38%) Lost to follow-up n = 1 (2.56%) Deceased n = 1 (2.56%) | 27 M–F (= 87.1%) completed the QoL questionnaire, hormone therapy | Moderate to high: selection bias |
Cardoso da Silva et al. ( )* | 75.26%* (n= 30 M–F [15.7%] excluded) | — | Dropout rate very high, no reasons given 31 M–F (65.95%) had corrective surgery, hormone therapy | Moderate to high: selection bias, attrition bias |
Castellano et al. ( ) | 11.76% | Non-respondents n= 8 (11.76%) | Only the domain general quality of life score and subdomains ‧sexuality and body were requested, hormone therapy | Moderate to high: selection bias Moderate: detection bias |
Jokic-Begic et al. ( ) | 25% | Lost to follow-up n = 1 (12.5%) Refused participation n = 1 (12.5%) | Very small study population, socioeconomic and clinical circumstances, psychotherapy, hormone therapy | Moderate to high: selection bias |
Kuhn et al. ( ) | — | — | No detail on interventions in the control group,no separate data analysis for M–F and F–M, hormone therapy | Moderate to high: selection bias, bias owing to deviations in interventions |
Lindqvist et al. ( )* | 77.37%* | Deceased or moved without changing address and entry in residents‘ register | Very high dropout rate, only 17 patients completed the questionnaire at all 4 follow-up points, hormone therapy | Moderate to high: selection bias, attrition bias |
Papadopulos et al. ( ) | 61.15% | Unavailable/incorrect phone number n = 38 (31.40%) Refused participation n = 14 (11.57%) Quesionnaire not completed n = 22 (18.18%) | Inclusion criteria: only patients who had had corrective surgery or those who did not require such surgery, hormone therapy | Moderate to high: selection bias |
Parola et al. ( ) | — | — | Hormone therapy | Moderate to high: selection bias |
van der Sluis et al. ( ) | 62.5% | Non-respondents n = 6 (25%) Lost to follow-up n = 3 (12.5%) Deceased n = 5 (20.84%) Refused participation n = 1 (4.16%) | Small study population Secondary vaginoplasty Hormone therapy | Moderate to high: selection bias |
Weyers et al. ( ) | 28.57% | Non-respondents n= 17 (24.29%) Refused participation n=3 (4.29%) | Hormone therapy | Moderate to high: selection bias |
Yang et al. ( ) | — | — | n = 73 (34.92%) had facial feminization surgery n = 43 (20.57%) had breast augmentation surgery Only n = 4 (1.91%) had sex reassignment surgery Socioeconomic and clinical circumstances Hormone therapy in only n = 37 (17.7%) | Moderate to high: selection bias, bias owing to deviations in interventions |
Zimmermann et al. ( ) | 55.56% | Non-respondents n = 45 (50%) Incomplete questionnaire n = 3 (3.34%) Inclusion criteria not met n = 2 (2.23%) | Absolute values from FLZ questionnaire not shown, only p-values reported, no separate evaluation of FLZ questionnaire for F–M and M–F, hormone therapy | Moderate to high: selection bias |
* 1 M–F male to female; F–M female to male, reassignment surgery
* 2 Prospective study design
* 3 Of originally 190 participants, n = 160 (84.21%) completed the questionnaire preoperatively and n = 47 (24.73%) postoperatively
* 4 Out of a total of 190 study participants, n = 146 (76.84%) completed the questionnaire preoperatively, n = 108 (56.84%) 1 year postoperatively, n = 64 (33.68%) 3 years postoperatively, and n = 43 (22,63%) 5 years postoperatively. Most of the 190 participants completed the questionnaire at least at two follow-up points.
The studies made use of the following instruments:
None of the questionnaires constitutes an investigative tool that is specifically tailored to trans persons. Table 3 shows the result scales. Table 2 shows the confounding variables and, as far as it is possible to assess this, the risk of bias.
SF-36 ( , , – ) | 36 items | 0 | 100 |
WHOQOL-100 ( , ) | 100 items | 0 | 100 |
SHS ( – ) | VAS, 4 items on a 7 point Likert scale | 4 | 28 |
SWLS ( – ) | VAS, 5 items on a 7 point Likert scale | 5 | 35 |
CLLS ( – ) | VAS, short scale (L-1) | 0 | 10 |
*For the studies referenced in parentheses, it was not possible to calculate effect sizes
The SF-36 and WHOQOL-100 are validated, reliable and disease–non-specific instruments for measuring health-related quality of life ( 30 , 31 ). They can be used to gain information on the individual health status and allow for observing disease-related stresses over time. The questionnaires collect data on numerous aspects of daily life, which in their totality reflect quality of life. They are used internationally and therefore make cross-cultural studies an option ( 32 ).
Studies that used the SF-36 to answer the question of postoperative quality of life ( 18 , 20 , 22 – 25 ) observed after sex reassignment surgery an improvement in “social functioning”, “physical” and “emotional role functioning”, “general health perceptions”, “vitality”, and “mental health” (p = 0.025 to p >0.05). In two of these studies ( 22 , 24 ), “mental health” in trans women after sex reassignment surgery did not differ significantly from the standard sample. This explains the formally non-significant result. Ainsworth and Spiegel ( 22 ) showed that trans women without surgical intervention when compared indirectly with cis women from the SF-36 standard sample reported significantly poorer “mental health” (39.5 vs 48.9; p <0.05). Lindqvist et al. ( 23 ) and Weyers et al. ( 24 ) found an improvement in “self-perceived health” in the first postoperative year (p <0.05 and p <0.009), which deteriorated later but did not fall as low as its original score (p <0.0001). Furthermore, the studies concluded that “physical pain” increased postoperatively and “physical functioning” decreased; the postoperative follow-up periods varied between 3 months ( 18 ) and 5 years ( 23 ). According to Lindqvist et al. ( 23 ), “physical pain” in trans women five years postoperatively was comparable to that in the standard population (72.5 vs 72.7; SD 26.5).
Studies that used the WHOQOL-100 came up with the following results: Cardoso da Silva et al. ( 26 ) observed postoperatively an increase in “sexual activity” (p = 0.000) compared with the preoperative evaluation (prospective study design). Furthermore they found a postoperative improvement in the “psychological domain” (p = 0.041) and “social relationships” (p = 0.007), but a deterioration in “physical health” (p = 0.002) and “independence” (p = 0.031). Accordingly, deteriorations were seen in the areas of “energy” and “fatigue”, “sleep”, “negative feelings”, “mobility”, and “activities of daily living” (p <0.05). Castellano et al. ( 17 ) found after sex reassignment surgery for the group of trans women compared with the group of cis women no significant differences relating to “sexual activity” (65.85 vs 66.28; p >0.05), “body image” (64.64 vs 65.47; p >0.05), and the “quality of life score” (67.87 vs 69.49; p >0.05).
The King’s Health Questionnaire (KHQ) is a validated questionnaire for evaluating the impact of urinary incontinence on quality of life ( 33 ), a topic of central importance for trans persons ( 34 ). This questionnaire interrogates the quality of life domains always in association with urinary incontinence as the main problem. Kuhn et al. ( 19 ) showed that “general health” in trans persons was experienced as poorer to a relevant extent (Cohen’s d = 4.126; p = 0.019), and “physical” (d = -7.972; p <0.0001) and “personal limitations” (d = -7.016; p <0.001) were experienced to a greater extent. In contrast to this, trans persons felt less limited in terms of “role limitation” (d = 3.311; p = 0.046). For “emotions”, “sleep”, “incontinence”, and “symptom severity”, the differences to the control group did not reach significance. The control group consisted of cis women who had undergone abdominopelvic surgery. The evaluation of the visual analogue scale (VAS) showed a lower (d = 14.136; p <0.0001) degree of general life satisfaction in the group of trans persons.
The SHS ( 35 ), SWLS ( 36 ), and CLLS ( 37 ) are validated and internationally used visual analogue scales to evaluate life satisfaction. The SHS evaluates individual happiness and associated physical, mental, and social wellbeing ( 35 ). The SWLS was used as a short-form scale in the cited studies (also known as L-1) and included only the question on general life satisfaction ( 36 ). The CLLS evaluates emotional wellbeing associated with life satisfaction as well as subjective health ( 37 ).
Studies that used the SHS, SWLS, and CLLS ( 27 , 28 ) to evaluate postoperative life satisfaction reported a high degree of “subjective happiness” (5.6; SD 1.4 and 5.9; SD 0.6), of “satisfaction with life“ (27.7; SD 5.8 and 27.1; SD 2.1) and “subjective wellbeing” (8.0 [range: 4–10] and 7.9; SD 0.7) in trans women after intestinal vaginoplasty. The studies cited earlier differ with regard to the following items: Bouman et al. ( 27 ) studied a population of young trans women (mean age: 19.1 years) with penoscrotal hypoplasia after primary laparoscopic intestinal vaginoplasty. The study participants had received puberty blockers during their transition therapy, which resulted in penoscrotal hypoplasia and made penile inversion vaginoplasty ( box ) impossible. Van der Sluis et al. ( 28 ) studied an older population (mean age: 58 years) of trans women after secondary intestinal vaginoplasty—that is, patients who required secondary intestinal reconstruction owing to vaginal stenosis or insufficient vaginal length after penile inversion vaginoplasty. The postoperative follow-up period varied between 1–7.5 years ( 27 ) and 17.2–34.3 years ( 28 ). In spite of the different patient populations, these studies found that sex reassignment surgery had a positive effect on life satisfaction.
The FLZ is a validated multidimensional questionnaire for evaluating individual general life satisfaction ( 38 ). It is used in life quality and rehabilitation research and enables the recording of changes if administered repeatedly. It is available in a German language version only; for this reason, its results apply only to German speaking populations.
Studies that used the FLZ questionnaire ( 21 , 29 ) found that the postoperative life satisfaction of trans women in terms of “health” does not differ from that of the general population. Additionally, Papadopoulos et al. ( 29 ) found no differences for “friends”, “hobbies”, “income”, “work”, and “relationship.” A subanalysis of the module “health” found postoperatively in both studies a relevant decrease in “fitness” (d = 0.521; p <0.001) and “energy” (d = 0.494; p <0.003). Zimmerman et al. ( 21 ) additionally found a significant decrease in “ability to relax/equilibrium” (p = 0.002), “fearlessness/absence of anxiety” (p = 0.015), and “absence of discomfort/pain” (p = 0.037). Both studies ( 21 , 29 ) were retrospective surveys that were undertaken once only in a time period between 6 months and 58 months postoperatively. Papadopoulos et al. ( 29 ) included only subjects into the study who did not require any further corrective surgery after sex reassignment surgery or who had already undergone a second procedure for the purpose of minor corrections.
Two prospective studies documented postoperatively a notable improvement in quality of life ( 23 , 26 ). Four studies found that the life quality of trans women after sex reassignment surgery was no different from that of cis women ( 17 , 20 , 22 , 24 ). Sex reassignment surgery has also been shown to have a positive effect on life satisfaction ( 27 , 28 )—the exception was urinary incontinence, in which case life satisfaction dropped ( 19 ). Lindqvist et al. ( 23 ) and Weyers et al. ( 24 ) observed an improvement in self-perceived health in the first postoperative year, which then drops, albeit not all the way down to its original level. This is consistent with the honeymoon phase described by De Cuypere et al. ( 39 ), which has been described as a euphoric period in the first year after surgery. Several studies ( 18 , 20 – 25 ) showed that physical pain increased after surgery and physical functioning deteriorated. This is easily explained by the surgery itself, however; the postoperative follow-up periods in these studies varied between 3 months ( 18 ) and 5 years ( 23 ).
Altogether the study results imply that sex reassignment surgery has an overall positive effect on partial aspects, such as mental health, sexuality, life satisfaction, and quality of life.
These results were confirmed by Barone et al. ( 40 ) and Murad et al. ( 15 ) in their review articles, which were published in 2017 and 2010, respectively. Barone et al. ( 40 ) in a systematic review evaluated patient reported results after sex reassignment surgery; among others, regarding life satisfaction. Murad et al. ( 15 ) in a meta-analysis focused on quality of life and psychosocial health after hormone therapy (main aspect) and sex reassignment surgery. In sum, both studies found improvements in quality of life and life satisfaction after sex reassignment surgery, and an improvement at the psychosocial level. Hess et al. ( 11 ) concluded that the study participants benefited from sex reassignment surgery—they too found high rates of satisfaction postoperatively in Germany.
As sex reassignment surgery often constitutes the final step of sex reassignment measures, hormone therapy as well as accompanying psychotherapy may have had a confounding effect. Not all studies adjusted for confounding factors. A lack of randomization and control or the use of a matched control group ( 17 , 19 ) in the studies also introduced methodological bias ( table 2 ). Furthermore, the high dropout rates of 12% ( 17 ) to 77% ( 23 ) (median: 56%), which are mainly due to non-respondents, should be assessed critically. In our experience, however, the patient population of trans women is often reticent and is not interested in study participation because of personal reasons (“to not be reminded of that time”). Other authors have shared this observation ( 18 , 24 ), which may also explain the occasionally high dropout rates. There is also the possibility that dissatisfied patients were among the dropouts. Owing to socioeconomic and clinical conditions, the studies from Croatia ( 18 ) and China ( 25 ) need to be evaluated separately. On the one hand, the authors of both studies draw attention to the public’s lack of awareness and understanding (and the associated psychological stress for trans women) in these countries, and, on the other hand, statutory sickness funds did not cover the costs of all treatments, which were therefore accessible to only few patients. This explains the notably lower participant numbers of 3 ( 18 ) and 4 ( 25 ) male-to-female transitions after sex reassignment surgery. None of the included studies reported potential suicide rates.
The strength of this review lies in the fact that we included only studies that used standardized questionnaires. Tests (such as the SF-36 or WHOQOL-100) represent validated and reliable measuring instruments, for some of which reference standard populations exist, and they enable international and intercultural comparison. Furthermore, standardized questionnaires have the advantage of a high degree of objectivity in terms of conducting, evaluating, and interpreting studies.
The available study data show that sex reassignment surgery has a positive effect on partial aspects—such as mental health/wellbeing, sexuality, and life satisfaction—as well as on quality of life overall.
It should be noted that the studies are almost exclusively retrospective analyses of mostly uncontrolled and small cohorts, for which no valid or specific measuring instruments are available to date. Because of the high dropout and non-response rates, the current data should be interpreted with caution.
In spite of the essentially positive results, the data are not satisfactory at this point in time. Due to the studies’ limited follow-up times, no conclusions can be drawn as yet about the long term consequences of such procedures. Furthermore, many studies did not use standardized questionnaires and/or scores, which makes comparisons between individual studies difficult.
Acknowledgments.
Translated from the original German by Birte Twisselmann, PhD.
Conflict of interest statement
The authors declare that no conflict of interest exists.
IMAGES
VIDEO
COMMENTS
Gender-affirming surgery is a durable treatment that improves overall patient well-being. High patient satisfaction, improved dysphoria, and reduced mental health …